234 related articles for article (PubMed ID: 29763892)
1. Interleukin-33 Predicts Poor Prognosis and Promotes Renal Cell Carcinoma Cell Growth Through its Receptor ST2 and the JNK Signaling Pathway.
Wu CW; Wu YG; Cheng C; Hong ZD; Shi ZM; Lin SQ; Li J; He XY; Zhu AY
Cell Physiol Biochem; 2018; 47(1):191-200. PubMed ID: 29763892
[TBL] [Abstract][Full Text] [Related]
2. The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma.
Zhou Y; Tong L; Chu X; Deng F; Tang J; Tang Y; Dai Y
Cell Physiol Biochem; 2017; 43(2):733-742. PubMed ID: 28950257
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
4. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
[TBL] [Abstract][Full Text] [Related]
5. ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway.
Zhang G; Yu Z; Fu S; Lv C; Dong Q; Fu C; Kong C; Zeng Y
Cancer Gene Ther; 2019 Sep; 26(9-10):323-333. PubMed ID: 30459398
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
[TBL] [Abstract][Full Text] [Related]
7. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
[TBL] [Abstract][Full Text] [Related]
8. PLEKHO1 knockdown inhibits RCC cell viability in vitro and in vivo, potentially by the Hippo and MAPK/JNK pathways.
Yu Z; Li Q; Zhang G; Lv C; Dong Q; Fu C; Kong C; Zeng Y
Int J Oncol; 2019 Jul; 55(1):81-92. PubMed ID: 31180521
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.
Kim JY; Lim SC; Kim G; Yun HJ; Ahn SG; Choi HS
Oncogene; 2015 Sep; 34(38):4928-38. PubMed ID: 25531326
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.
Tong X; Barbour M; Hou K; Gao C; Cao S; Zheng J; Zhao Y; Mu R; Jiang HR
Mol Oncol; 2016 Jan; 10(1):113-25. PubMed ID: 26433471
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-33/ST2 Signaling Promotes Hepatocellular Carcinoma Cell Stemness Expansion Through Activating c-Jun N-terminal Kinase Pathway.
Zhao R; Yu Z; Li M; Zhou Y
Am J Med Sci; 2019 Oct; 358(4):279-288. PubMed ID: 31420092
[TBL] [Abstract][Full Text] [Related]
13. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
[TBL] [Abstract][Full Text] [Related]
14. HECTD2/TNFAIP1 Axis Regulating the p38/JNK Pathway to Promote an Inflammatory Response in Renal Cell Carcinoma Cells.
Lv D; Chen Y; Tang L; Tian Y; Ren D; Jian N; Shen T
In Vivo; 2024; 38(3):1094-1103. PubMed ID: 38688591
[TBL] [Abstract][Full Text] [Related]
15. MCP-1/MCPIP-1 Signaling Modulates the Effects of IL-1β in Renal Cell Carcinoma through ER Stress-Mediated Apoptosis.
Lee CH; Hung PF; Lu SC; Chung HL; Chiang SL; Wu CT; Chou WC; Sun CY
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31816951
[TBL] [Abstract][Full Text] [Related]
16. Cyanidin Curtails Renal Cell Carcinoma Tumorigenesis.
Liu X; Zhang D; Hao Y; Liu Q; Wu Y; Liu X; Luo J; Zhou T; Sun B; Luo X; Xu J; Wang Q; Yang Z; Li L
Cell Physiol Biochem; 2018; 46(6):2517-2531. PubMed ID: 29742507
[TBL] [Abstract][Full Text] [Related]
17. ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma.
Wu DS; Chen C; Wu ZJ; Liu B; Gao L; Yang Q; Chen W; Chen JM; Bao Y; Qu L; Wang LH
J Exp Clin Cancer Res; 2016 Jul; 35(1):108. PubMed ID: 27377902
[TBL] [Abstract][Full Text] [Related]
18. Cordycepin promotes apoptosis in renal carcinoma cells by activating the MKK7-JNK signaling pathway through inhibition of c-FLIPL expression.
Hwang IH; Oh SY; Jang HJ; Jo E; Joo JC; Lee KB; Yoo HS; Lee MY; Park SJ; Jang IS
PLoS One; 2017; 12(10):e0186489. PubMed ID: 29045468
[TBL] [Abstract][Full Text] [Related]
19. The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation.
Lin L; Li Y; Liu M; Li Q; Liu Q; Li R
Aging (Albany NY); 2020 Jan; 12(2):1685-1703. PubMed ID: 32003751
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent up-regulation of DNMT1 or DNMT3b.
Quan Z; He Y; Luo C; Xia Y; Zhao Y; Liu N; Wu X
Cell Signal; 2017 Apr; 32():48-58. PubMed ID: 28093267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
